Tech Company Financing Transactions
Bugworks Research Funding Round
Bugworks Research, operating out of Wilmington, secured $9 million in funding from UTEC, 3one4 Capital and Acquipharma Holdings.
Transaction Overview
Company Name
Announced On
8/16/2018
Transaction Type
Venture Equity
Amount
$9,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2711 Centerville Rd. 400
Wilmington, DE 19808
USA
Wilmington, DE 19808
USA
Phone
Website
Email Address
Overview
AMR is a global emergency impacting millions across the world, requiring next-generation novel antibiotics. Bugworks with its years of domain experience and through its innovative approaches has an exciting portfolio of broad-spectrum novel antibiotic assets at various stages of discovery and preclinical development.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Anand Anandkumar
Chief Scientific Officer
Santanu Datta
Vice President
Shahul Hameed
VP - R & D
V Balasubramanian
Browse more venture capital transactions:
Prev: 8/16/2018: Full Harvest venture capital transaction
Next: 8/16/2018: Voicify venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are derived from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs